Cytocom, Inc.
USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER
Last updated:
Abstract:
The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.
Status:
Application
Type:
Utility
Filling date:
19 Feb 2019
Issue date:
12 Sep 2019